Cite
HARVARD Citation
Boyle, F. et al. (n.d.). Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm. Asia-Pacific journal of clinical oncology. pp. 3-11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Boyle, F. et al. (n.d.). Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm. Asia-Pacific journal of clinical oncology. pp. 3-11. [Online].